<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03882411</url>
  </required_header>
  <id_info>
    <org_study_id>AAAR9175 - III</org_study_id>
    <secondary_id>1R01HL141609-01</secondary_id>
    <nct_id>NCT03882411</nct_id>
  </id_info>
  <brief_title>An IT Approach to Implementing Depression Treatment in Cardiac Patients (iHeart DepCare)</brief_title>
  <official_title>An Information tecHnology Approach to implEmenting Depression treAtment in caRdiac patienTs: [iHeartDepCare Trial]</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effect of a brief electronic shared decision&#xD;
      making (eSDM) intervention on depressive symptoms in coronary heart disease patients with&#xD;
      elevated depressive symptoms.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Depression is common in patients with coronary heart disease and associated with increased&#xD;
      cardiac morbidity and mortality. Treating depressive symptoms appears to improve depressive&#xD;
      symptoms and quality of life. Despite expert recommendations to screen and treat depressive&#xD;
      symptoms fewer coronary heart disease patients engage in depression treatment than the&#xD;
      general population, perhaps due to 1) sub-optimal provider awareness and referral rates and&#xD;
      2) low self-efficacy, stigma and misattribution of depressive symptoms among coronary heart&#xD;
      disease patients. In addition, few real world theory-informed implementation trials exist for&#xD;
      improving screening and treatment in outpatient settings.&#xD;
&#xD;
      The specific aim is to determine whether an electronic shared decision making (eSDM) and&#xD;
      behavioral activation tool improves depressive symptoms and treatment initiation in coronary&#xD;
      heart disease patients with elevated depressive symptoms. To accomplish these aims, a hybrid&#xD;
      effectiveness-implementation trial will be conducted using a stepped wedge design across&#xD;
      socioeconomically diverse cardiology and primary care clinics.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 23, 2019</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Stepped Wedge Design with 8 clinics randomized to timing of receipt of intervention. More clinics may be enlisted in the event that a sufficient number of participants from the initial 8 clinics is not achieved.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Beck Depression Index (BDI-II)</measure>
    <time_frame>Baseline, Follow-up visit (approximately 6 months)</time_frame>
    <description>Change in total BDI (21-item measure of depressive symptoms [0-63]; higher score constitutes worse burden of symptoms) from baseline to follow visit during the pre-intervention period compared to post-intervention period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who initiate treatment</measure>
    <time_frame>Baseline, Follow-up visit (approximately 6 months)</time_frame>
    <description>Proportion of enrolled patients who initiate any depression treatment (medications, cardiac rehab/exercise program, therapy) from baseline to follow up visit in the pre-intervention compared to post-intervention period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in quality of life years (QALYs)</measure>
    <time_frame>Baseline, Follow-up visit (approximately 6 months)</time_frame>
    <description>Change in QALYs from from baseline to follow up visit in the pre-intervention compared to post-intervention period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Patient Activation</measure>
    <time_frame>Baseline</time_frame>
    <description>Mean baseline patient activation measure [PAM] (13-items, range 0-100, higher score indicates greater activation] in the pre-intervention compared to post-intervention period</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">368</enrollment>
  <condition>Depressive Symptoms</condition>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>Electronic shared decision making (eSDM) Tool</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>When a clinic's randomly allotted intervention period arrives, coronary heart disease patients in a given cluster of clinics will complete a web application, which delivers screening, behavioral activation and shared decision making (eSDM), and providers will receive a patient preference report generated from the application.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In the year prior to the allocated intervention period, coronary heart disease patients will receive usual care from their providers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Electronic shared decision making (eSDM) tool</intervention_name>
    <description>The web application includes depression screening, behavioral activation, and a patient preference driven treatment selection decision aid. Treatment options will include medications, cardiac rehab/exercise program, and therapy. Providers will receive a patient preference report in real time with options for coordination of care.</description>
    <arm_group_label>Electronic shared decision making (eSDM) Tool</arm_group_label>
    <other_name>eSDM intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  History of coronary heart disease&#xD;
&#xD;
          -  English or Spanish Speaking&#xD;
&#xD;
          -  Elevated Depressive symptoms (PHQ9 â‰¥10)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under the care of a psychiatrist (e.g., for schizophrenia)&#xD;
&#xD;
          -  Diagnosis/history of psychosis or schizophrenia&#xD;
&#xD;
          -  Diagnosis/history of bipolar disorder&#xD;
&#xD;
          -  Attempted suicide&#xD;
&#xD;
          -  Non-English or Spanish speaking&#xD;
&#xD;
          -  Dementia or severe cognitive impairment&#xD;
&#xD;
          -  Non-elevated depressive symptoms&#xD;
&#xD;
          -  Alcohol or substance abuse&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathalie Moise, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nathalie Moise, MD, MS</last_name>
    <phone>2123422889</phone>
    <email>nm2562@cumc.columbia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Columbia University Irving Medical Center/New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Moise, MD, MS</last_name>
      <phone>212-342-2889</phone>
      <email>nm2562@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Nathalie Moise, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 15, 2019</study_first_submitted>
  <study_first_submitted_qc>March 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 20, 2019</study_first_posted>
  <last_update_submitted>September 23, 2020</last_update_submitted>
  <last_update_submitted_qc>September 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Nathalie Moise</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine, Dept of Medicine</investigator_title>
  </responsible_party>
  <keyword>Implementation science</keyword>
  <keyword>Stepped wedge design</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

